StockData
Q/C Technologies, Inc. logo

Q/C Technologies, Inc. (QCLS) stock

QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.31−0.03 (-8.29%)

Close on Nov 18, 2026Market cap $2.51MP/E –Yield –

Q/C Technologies pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Q/C Technologies

Q/C Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Q/C Technologies figures

See a number that looks wrong?